Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
44.20
-0.34 (-0.76%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Vericel Revenue

Vericel had revenue of $77.46M in the quarter ending June 30, 2026, with 22.48% growth. This brings the company's revenue in the last twelve months to $306.30M, up 22.95% year-over-year. In the year 2025, Vericel had annual revenue of $276.26M with 16.45% growth.

Revenue (ttm)
$306.30M
Revenue Growth
+22.95%
P/S Ratio
7.39
Revenue / Employee
$769,606
Employees
398
Market Cap
2.26B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025276.26M39.04M16.45%
Dec 31, 2024237.22M39.71M20.10%
Dec 31, 2023197.52M33.15M20.17%
Dec 31, 2022164.37M8.18M5.24%
Dec 31, 2021156.18M32.01M25.77%
Dec 31, 2020124.18M6.33M5.37%
Dec 31, 2019117.85M26.99M29.71%
Dec 31, 201890.86M26.93M42.13%
Dec 31, 201763.92M9.54M17.54%
Dec 31, 201654.38M3.22M6.28%
Dec 31, 201551.17M22.37M77.69%
Dec 31, 201428.80M28.78M151,457.89%
Dec 31, 201319.00K-2.00K-9.52%
Dec 31, 201221.00K3.00K16.67%
Dec 31, 201118.00K-71.00K-79.78%
Jun 30, 201089.00K-93.00K-51.10%
Jun 30, 2009182.00K-340.00K-65.13%
Jun 30, 2008522.00K-163.00K-23.80%
Jun 30, 2007685.00K-178.00K-20.63%
Jun 30, 2006863.00K-46.00K-5.06%
Jun 30, 2005909.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Harmony Biosciences Holdings959.90M
ADMA Biologics512.28M
UroGen Pharma188.73M
Nuvation Bio169.90M
Septerna98.88M
Mesoblast65.38M
Ocular Therapeutix52.06M
Revenue Rankings